Samuel Whiting - 22 Jun 2022 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Medical Officer
Signature
/s/ Pierre Lorenzo, Attorney-in-Fact for Samuel Whiting
Issuer symbol
TPST
Transactions as of
22 Jun 2022
Net transactions value
$0
Form type
4
Filing time
22 Jun 2022, 16:32:59 UTC
Previous filing
10 Jan 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (Right to Buy) Award $0 +55,680 $0.000000 55,680 21 Jun 2022 Common Stock 55,680 $2.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over four (4) years, with one-fourth (1/4) of the award vesting on the first anniversary of the date of grant and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.